NCT02839096

Once Versus Twice Daily Iron Supplementation in Pregnant Women

Once Daily Versus Twice Daily Iron Supplementation to Treat Anemia in Pregnancy: A Prospective, Randomized, Placebo Controlled, Double Blinded, Clinical Trial

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 20 (actual)
• Sponsor: University of Missouri-Columbia · Academic / Other
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The investigators will randomize women diagnosed with anemia in the mid-trimester of pregnancy to once or twice daily iron supplementation

Detailed description

Women defined as having iron deficiency anemia based on a low hemoglobin as defined by the American College of Obstetrics and Gynecology and a low serum ferritin, in the absence of hemoglobinopathy, will be randomized to ferrous sulfate 325mg PO daily or PO twice daily.

Conditions

• Anemia in Pregnancy

Interventions

Type	Name	Description
DRUG	Placebo	Cellulose placebo that will be used in place of a second dose of ferrous sulfate in the subjects randomized to once daily dosing of ferrous sulfate
DRUG	Ferrous Sulfate	Subjects will receive once or twice daily dosing of ferrous sulfate. This will be provided by our hospital pharmacy and be identical in appearance to the placebo.

Timeline

• Start date: 2016-06-01
• Primary completion: 2019-06-01
• Completion: 2019-12-01
• First posted: 2016-07-20
• Last updated: 2024-09-19
• Results posted: 2024-09-19

Locations

1 site across 1 country: United States